Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows a newer revision version (v3.5.4) replacing the previous v3.5.3, indicating an update to the page version without altering the underlying study data.
    Difference
    0.0%
    Check dated 2026-05-15T14:22:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov site’s displayed release/version from **v3.5.2** to **v3.5.3** without changing any study content.
    Difference
    0.0%
    Check dated 2026-04-24T06:18:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:43.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:30:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor maintenance update and does not affect the study information presented.
    Difference
    0.0%
    Check dated 2026-03-12T02:33:06.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the government funding lapse notice and Revision: v3.4.1, representing administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:23.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.